Affirm Holdings Inc
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
AFRM$65.95-3.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Three Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities | ||
| Net loss | $(100,222) | $(171,783) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Provision for losses | 159,824 | 99,696 |
| Amortization of premiums and discounts on loans | (52,064) | (41,138) |
| Gain on sales of loans | (63,613) | (34,285) |
| Gain on extinguishment of debt | (19,624) | — |
| Changes in fair value of assets and liabilities | 1,668 | (4,110) |
| Amortization of commercial agreement assets | 14,256 | 21,557 |
| Amortization of debt issuance costs | 6,083 | 5,534 |
| Amortization of discount on securities available for sale | (15,797) | (12,120) |
| Commercial agreement warrant expense | 107,263 | 95,910 |
| Stock-based compensation | 94,233 | 112,359 |
| Depreciation and amortization | 46,720 | 40,131 |
| Impairment of right of use assets | — | 752 |
| Other | (2,209) | (4,730) |
| Change in operating assets and liabilities: | ||
| Purchases and origination of loans held for sale | (1,219,022) | (1,222,224) |
| Proceeds from the sale of loans held for sale | 1,219,061 | 1,228,110 |
| Accounts receivable, net | 41,117 | (42,208) |
| Other assets | (6,833) | (12,566) |
| Accounts payable | 16,543 | (1,257) |
| Payable to third-party loan buyers | (7,608) | 55,646 |
| Accrued interest payable | 846 | 6,264 |
| Accrued expenses and other liabilities | (23,755) | (20,636) |
| Net cash provided by operating activities | 196,867 | 98,902 |
| Cash flows from investing activities | ||
| Purchases and origination of loans held for investment | (6,388,350) | (4,229,667) |
| Proceeds from the sale of loans held for investment | 1,630,671 | 899,238 |
| Principal repayments and other loan servicing activity | 4,132,682 | 3,184,851 |
| Additions to property, equipment and software | (44,152) | (35,817) |
| Purchases of securities available for sale | (136,727) | (96,813) |
| Proceeds from maturities and repayments of securities available for sale | 215,680 | 262,293 |
| Other investing cash inflows | 15,197 | 56 |
| Net cash used in investing activities | (574,999) | (15,859) |
| Cash flows from financing activities | ||
| Proceeds from funding debt | 3,188,998 | 2,896,251 |
| Payment of debt issuance costs | (4,321) | (10,490) |
| Principal repayments of funding debt | (3,289,384) | (2,938,674) |
| Extinguishment of convertible debt | (120,056) | — |
| Proceeds from issuance of notes and certificates by securitization trust | 750,000 | 750,000 |
| Principal repayments of notes issued by securitization trust | — | (515,377) |
| Proceeds from exercise of common stock options and warrants and contributions to ESPP | 3,596 | 3,611 |
| Payments of tax withholding for stock-based compensation | (63,208) | (36,515) |
| Net cash provided by financing activities | 465,625 | 148,806 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1,730 | (3,301) |
| Net increase in cash, cash equivalents and restricted cash | 89,223 | 228,548 |
| Cash, cash equivalents and restricted cash, beginning of period | 1,295,399 | 1,259,944 |
| Cash, cash equivalents and restricted cash, end of period | $1,384,622 | $1,488,492 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.